Anika Therapeutics Inc. Revenue 2009–2025
Anika Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Anika Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 29.6 M, a 13.16% increase year-over-year.
- Anika Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 111.8 M, a 14.49% decrease year-over-year.
- Anika Therapeutics Inc. annual revenue for 2025 was 112.8 M, a 5.91% decrease from 2024.
- Anika Therapeutics Inc. annual revenue for 2024 was 119.9 M, a 0.73% decrease from 2023.
- Anika Therapeutics Inc. annual revenue for 2023 was 120.8 M, a 6.12% increase from 2022.
- Anika Therapeutics Inc. annual revenue for 2022 was 113.8 M.
Anika Therapeutics Inc. (ANIK) — Frequently Asked Questions
Anika Therapeutics Inc. (ANIK) is a publicly traded US company. It has a market capitalization of $212M. In fiscal 2025 it reported revenue of $113M and net income of -$11M. Explore ANIK's stock price, financial statements, earnings history, margins and key ratios below.
What is Anika Therapeutics Inc.'s market cap?
Anika Therapeutics Inc. (ANIK) has a market capitalization of $212M.
What is the ANIK stock price?
ANIK trades at $14.81 (-0.87% on the day).
How much revenue does Anika Therapeutics Inc. make?
Anika Therapeutics Inc. reported revenue of $113M in fiscal 2025.
Is ANIK profitable?
In fiscal 2025, Anika Therapeutics Inc. reported net income of -$11M.